tirzepatide removed from shortage list Lilly's weight-loss drug FDA's Minus one of its GLP-1

Contraindications: Patients with certain medical conditions - including a personal or family history of thyroid cancer - may be excluded

The pricing information in this article was accurate at time of publication (January 2026) but may change

11 Moreover, leptin receptor expression has previously been coupled to the appetite inhibition of GLP-1, 22 and recent studies in rodents have shown that GLP-1RAs can restore leptin responsiveness

Trials run for obesity showed more biliary events than diabetes trials, consistent with the rapid-weight-loss mechanism

Anything that is new that we are considering offering to a patient, we want to make sure that we have done our research. Owens isnt alone other members of the medical practice have also turned to compounded versions of weight loss drugs